|
Protocol Number:
89-I-0174
- Title:
Study of Patients with Known or Suspected Infection with Strongyloides Stercoralis
- Number:
89-I-0174
- Summary:
This study will explore faster and easier ways to detect infection with the intestinal parasite Strongyloides stercoralis and learn more about the conditions under which it causes serious disease. Ordinarily, the Strongyloides helminth (type of intestinal worm) causes only few, if any, symptoms, but in people with weakened immunity it may be very serious, and even deadly.
People between 5 and 80 years of age with known or suspected S. stercoralis infection, or infection with another helminth, such as filariasis, that might cause a cross-reaction with S. stercoralis may be eligible for this study.
Participants found to be infected with S. stercoralis will be treated with ivermectin, thiabendazole, or albendazole. In addition, they will undergo the following tests and procedures:
- Blood tests and stool samples: Samples will be collected before and after treatment to check general health status and immune function, and to look for parasites in stool. Up to 50 milliliters (10 teaspoons) of blood will be drawn in adults and up to 25 ml (5 teaspoons) in children.
- Skin tests: A test similar to those used for tuberculosis and allergies will be conducted to determine if there is sensitization to products of the parasite. Such a test might be used as a rapid method to diagnose the infection. About three drops of several different antigens (proteins) are injected into the skin of the arm. After 15 to 20 minutes, the area is checked to see if a red spot has formed and, if so, the spot is measured.
- Sponsoring Institute:
-
National Institute of Allergy and Infectious Diseases (NIAID)
- Recruitment Detail
- Type:
Participants currently recruited/enrolled
- Gender:
Male & Female
- Referral Letter Required:
No
- Population Exclusion(s):
None
- Eligibility Criteria:
INCLUSION CRITERIA:
Age of 5 to 80 years and of either sex.
Access to primary medical care provider outside of the NIH
Ability to give written informed consent (for adults) and parental consent (for those under 18)
Presence of known or suspected infection with Stronglyloides stercoralis, such as significant peripheral blood eosinophilia (greater than 1000 eosinophils/mm(3)) for which no other cause is apparent.
Willingness to participate and provide blood for in vitro assays and serum storage.
EXCLUSION CRITERIA:
Less than 5 years of age
Pregnancy is not a criterion for exclusion.
- Special Instructions:
Currently Not Provided
- Keywords:
-
Strongyloidiasis
-
Immediate Hypersensitivity Skin Test
-
IgE
-
Nematode
-
Immunosuppression
-
Skin Test
-
Diagnosis
-
Intestinal Helminth
-
Immediate Hypersensitivity
- Recruitment Keyword(s):
-
None
- Condition(s):
-
HIV Infection
-
Nematode Infection
-
Strongyloidiasis
- Investigational Drug(s):
-
Strongyloides Stercoralis Skin Test Antigen
- Investigational Device(s):
- None
- Intervention(s):
- None
- Supporting Site:
- National Institute of Allergy and Infectious Diseases
- Contact(s):
-
Patient Recruitment and Public Liaison Office
Building 61 10 Cloister Court Bethesda, Maryland 20892-4754 Toll Free: 1-800-411-1222 TTY: 301-594-9774 (local),1-866-411-1010 (toll free) Fax: 301-480-9793 Electronic Mail:prpl@mail.cc.nih.gov
- Citation(s):
-
Biology and immunology of human strongyloidiasis
-
Strongyloides stercoralis hyperinfection in a carrier of HTLV-1 virus with evidence of selective immunosuppression
-
Intradermal reactions in strongyloidiasis
If you have:
Search The Studies | Help | Questions | Clinical Center Home | NIH Home
National Institutes of Health Clinical Center
Bethesda, Maryland 20892. Last update: 05/05/2009
|
|